As discussed in greater detail in prior articles, the Coronavirus Aid, Relief and Economic Security Act (CARES Act) authorized the USPTO to extend certain statutory deadlines in response to the COVID-19 pandemic. On March 31, the USPTO exercised that authority by providing a 30-day extension of certain due dates in patent and trademark matters that had an original due date between March 27 and April 30, 2020. On April 28, the USPTO further extended deadlines to June 1, 2020. However, the most recent extension to July 1 applies only to small and micro-entities.
“The USPTO has already extended various deadlines twice, with the latest extension expiring at the end of this month. However, the USPTO recognizes that the COVID-19 pandemic continues to impose various hardships, especially on small businesses and individual inventors,” the USPTO said in a press statement. “Accordingly, as stakeholders continue to navigate the effects of the pandemic in various ways, and as more and more of them are resuming operations, the USPTO will again extend certain deadlines.”
Extension of Patent Fees and Deadlines
For small and micro entities, filings that would have been deemed timely filed, if filed by June 1, 2020 pursuant to the CARES Act Notice dated April 28, 2020, will now be deemed timely filed if filed by July 1, 2020. For large entities, after May 31, 2020, relief will be available to those who need it on a case-by-case basis. The USPTO advises that requests can be submitted through a petition for an extension of time or a petition to revive.
As set forth in the USPTO’s official notice, it is also extending its waiver of the petition fee for filing a petition for the revival of applications that became abandoned on or before June 30, 2020, if accompanied by a statement that the delay in filing or payment was due to the COVID-19 outbreak.
Extension of Trademark Fees and Deadlines
With regard to trademark fees and deadlines, the USPTO is also providing relief on a case-by-case basis. As set forth in the USPTO’s official notice, relief will be granted as follows:
Applicants who were unable to submit a timely response or fee in response to an Office communication can file a petition to revive the application.
Applicants who missed the 36-month statutory deadline for filing a Statement of Use, and therefore their application has been abandoned, should use the TEAS “Petition to the Director” form.
Registrants who missed a statutory deadline, resulting in a cancelled/expired registration, or who were unable to submit a timely response or fee in response to an Office communication regarding a registration, should use the TEAS “Petition to the Director” form.
The USPTO will continue to waive the petition fee for petitions to revive applications or reinstate registrations that became abandoned or expired/cancelled as a result of the COVID-19 outbreak, with a statement that the delay in filing or payment was due to the COVID-19 outbreak. With regard to proceedings before the TTAB, if the COVID-19 outbreak has prevented or interfered with a filing, parties can make a request (in ex-parte appeals) or motion (for trial cases) for an extension or reopening of time, as appropriate.
As with prior extensions, a delay is “due” to the COVID-19 outbreak when the outbreak materially interfered with the filing of a paper or fee. Circumstances that qualify as materially interfering include, without limitation, office closures, cash flow interruptions, lack of access to files or other materials, travel delays, personal or family illness, or other similar circumstances. The person affected by the outbreak may be a practitioner, applicant, patent owner, petitioner, third-party requester, inventor, or other person associated with the filing or fee.
Future Extensions
According to the USPTO, it will continue to evaluate the evolving situation around the COVID-19 outbreak and the impact on the USPTO’s operations and stakeholders. If the USPTO further extends the CARES Act relief, we will provide updates here. If you have any questions regarding anything to do with the USPTO or if you wish to discuss seeking registration of your intellectual property, please do not hesitate to reach out to any members of our team.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact me, Ivan Tukhtin, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
Nationwide Preliminary Injunction for CTA Filings Lifted
FinCEN Beneficial Owner Reporting Must be Completed by January 13 for pre-2024 Companies On December 23, 2024, the 5th Circuit Court of Appeals lifted the injunction that stayed the enforcement of the Corporate Transparency Act put into place by a federal judge in Texas. The result is that if you are required to file a […]
FinCEN Corporate Transparency Act filings shut down by the US District Court for the Eastern District of Texas
IMPORTANT UPDATE! FinCEN Corporate Transparency Act filings shut down by the US District Court for the Eastern District of Texas Under the Corporate Transparency Act (CTA), entities that were in existence before January 1, 2024 are required to file Beneficial Owner Reports (BOR) with the Financial Crimes Enforcement Network (FinCEN) before January 1, 2025. Requirements […]
New Intoxicating Hemp Law Will Dramatically Affect New Jersey Cannabis, Hemp, and Liquor Industries
On September 12, 2024, Gov. Phil Murphy signed controversial legislation that will dramatically alter New Jersey’s cannabis, hemp, and liquor industries. The new law aims to regulate the influx of intoxicating hemp products into the marketplace by bringing them under the purview of the New Jersey Cannabis Regulatory Commission (CRC). That means that edibles, THC-infused beverages, […]
Wheels Moving on Reclassification of Cannabis as AG Launches Rulemaking Process
On May 16, 2024, President Joe Biden announced that his administration is committed to reclassifying cannabis. Shortly thereafter, Attorney General Merritt Garland initiated the formal rulemaking process to move cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA). “This is monumental,” President Biden said in a video statement […]
Two PFAS Are Now Hazardous Substances under CERCLA
The U.S. Environmental Protection Agency (EPA) continues to take significant action regarding the regulation of per- and polyfluoroalkyl substances or PFAS. On April 19, 2024, the EPA released its Final Rule designating PFOA and PFOS as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), which will allow EPA to use the […]
Could Your EPA Civil Enforcement Matter Turn Criminal?
Parties involved in a civil enforcement matter by the U.S. Environmental Protection Agency (EPA) could soon find themselves facing even more serious criminal liability. On April 17, 2024, the EPA’s Office of Enforcement and Compliance Assurance announced a new “Strategic Civil-Criminal Enforcement Policy” (Policy). The Policy is effective immediately and applies to all civil and […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
USPTO Extends Patent & Trademark Deadlines Until July 1
Author: Scarinci Hollenbeck, LLC
The U.S. Patent and Trademark Office continues to extend deadlines for certain patent and trademark filings…
As discussed in greater detail in prior articles, the Coronavirus Aid, Relief and Economic Security Act (CARES Act) authorized the USPTO to extend certain statutory deadlines in response to the COVID-19 pandemic. On March 31, the USPTO exercised that authority by providing a 30-day extension of certain due dates in patent and trademark matters that had an original due date between March 27 and April 30, 2020. On April 28, the USPTO further extended deadlines to June 1, 2020. However, the most recent extension to July 1 applies only to small and micro-entities.
“The USPTO has already extended various deadlines twice, with the latest extension expiring at the end of this month. However, the USPTO recognizes that the COVID-19 pandemic continues to impose various hardships, especially on small businesses and individual inventors,” the USPTO said in a press statement. “Accordingly, as stakeholders continue to navigate the effects of the pandemic in various ways, and as more and more of them are resuming operations, the USPTO will again extend certain deadlines.”
Extension of Patent Fees and Deadlines
For small and micro entities, filings that would have been deemed timely filed, if filed by June 1, 2020 pursuant to the CARES Act Notice dated April 28, 2020, will now be deemed timely filed if filed by July 1, 2020. For large entities, after May 31, 2020, relief will be available to those who need it on a case-by-case basis. The USPTO advises that requests can be submitted through a petition for an extension of time or a petition to revive.
As set forth in the USPTO’s official notice, it is also extending its waiver of the petition fee for filing a petition for the revival of applications that became abandoned on or before June 30, 2020, if accompanied by a statement that the delay in filing or payment was due to the COVID-19 outbreak.
Extension of Trademark Fees and Deadlines
With regard to trademark fees and deadlines, the USPTO is also providing relief on a case-by-case basis. As set forth in the USPTO’s official notice, relief will be granted as follows:
Applicants who were unable to submit a timely response or fee in response to an Office communication can file a petition to revive the application.
Applicants who missed the 36-month statutory deadline for filing a Statement of Use, and therefore their application has been abandoned, should use the TEAS “Petition to the Director” form.
Registrants who missed a statutory deadline, resulting in a cancelled/expired registration, or who were unable to submit a timely response or fee in response to an Office communication regarding a registration, should use the TEAS “Petition to the Director” form.
The USPTO will continue to waive the petition fee for petitions to revive applications or reinstate registrations that became abandoned or expired/cancelled as a result of the COVID-19 outbreak, with a statement that the delay in filing or payment was due to the COVID-19 outbreak. With regard to proceedings before the TTAB, if the COVID-19 outbreak has prevented or interfered with a filing, parties can make a request (in ex-parte appeals) or motion (for trial cases) for an extension or reopening of time, as appropriate.
As with prior extensions, a delay is “due” to the COVID-19 outbreak when the outbreak materially interfered with the filing of a paper or fee. Circumstances that qualify as materially interfering include, without limitation, office closures, cash flow interruptions, lack of access to files or other materials, travel delays, personal or family illness, or other similar circumstances. The person affected by the outbreak may be a practitioner, applicant, patent owner, petitioner, third-party requester, inventor, or other person associated with the filing or fee.
Future Extensions
According to the USPTO, it will continue to evaluate the evolving situation around the COVID-19 outbreak and the impact on the USPTO’s operations and stakeholders. If the USPTO further extends the CARES Act relief, we will provide updates here. If you have any questions regarding anything to do with the USPTO or if you wish to discuss seeking registration of your intellectual property, please do not hesitate to reach out to any members of our team.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact me, Ivan Tukhtin, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
